| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 687125
[patent_doc_number] => 07078481
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-18
[patent_title] => 'Potassium channel interactors and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 09/670756
[patent_app_country] => US
[patent_app_date] => 2000-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 57319
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078481.pdf
[firstpage_image] =>[orig_patent_app_number] => 09670756
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/670756 | Potassium channel interactors and uses therefor | Sep 26, 2000 | Issued |
Array
(
[id] => 1130129
[patent_doc_number] => 06787355
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Multipotent neural stem cells from peripheral tissues and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/670049
[patent_app_country] => US
[patent_app_date] => 2000-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10375
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787355.pdf
[firstpage_image] =>[orig_patent_app_number] => 09670049
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/670049 | Multipotent neural stem cells from peripheral tissues and uses thereof | Sep 24, 2000 | Issued |
Array
(
[id] => 1151365
[patent_doc_number] => 06770742
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-03
[patent_title] => 'Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer'
[patent_app_type] => B1
[patent_app_number] => 09/600826
[patent_app_country] => US
[patent_app_date] => 2000-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10543
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770742.pdf
[firstpage_image] =>[orig_patent_app_number] => 09600826
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/600826 | Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer | Sep 6, 2000 | Issued |
| 09/622804 | Biotin-binding receptor molecules | Aug 21, 2000 | Abandoned |
Array
(
[id] => 1239449
[patent_doc_number] => 06686175
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor'
[patent_app_type] => B1
[patent_app_number] => 09/624594
[patent_app_country] => US
[patent_app_date] => 2000-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 22746
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686175.pdf
[firstpage_image] =>[orig_patent_app_number] => 09624594
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/624594 | IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor | Jul 24, 2000 | Issued |
Array
(
[id] => 1413884
[patent_doc_number] => 06525021
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Contulakin-G, analogs thereof and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/609534
[patent_app_country] => US
[patent_app_date] => 2000-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 33
[patent_no_of_words] => 20219
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 513
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525021.pdf
[firstpage_image] =>[orig_patent_app_number] => 09609534
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/609534 | Contulakin-G, analogs thereof and uses therefor | Jun 29, 2000 | Issued |
Array
(
[id] => 1228463
[patent_doc_number] => 06696408
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-24
[patent_title] => 'Contulakin-G, analogs thereof and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/606247
[patent_app_country] => US
[patent_app_date] => 2000-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 33
[patent_no_of_words] => 19618
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 531
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696408.pdf
[firstpage_image] =>[orig_patent_app_number] => 09606247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/606247 | Contulakin-G, analogs thereof and uses therefor | Jun 28, 2000 | Issued |
Array
(
[id] => 1478411
[patent_doc_number] => 06344551
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-05
[patent_title] => 'Contulakin-G, analogs thereof and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/605990
[patent_app_country] => US
[patent_app_date] => 2000-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 33
[patent_no_of_words] => 19607
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344551.pdf
[firstpage_image] =>[orig_patent_app_number] => 09605990
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/605990 | Contulakin-G, analogs thereof and uses therefor | Jun 28, 2000 | Issued |
Array
(
[id] => 1534868
[patent_doc_number] => 06489298
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Contulakin-G, analogs thereof and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/605991
[patent_app_country] => US
[patent_app_date] => 2000-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 33
[patent_no_of_words] => 19622
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 499
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489298.pdf
[firstpage_image] =>[orig_patent_app_number] => 09605991
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/605991 | Contulakin-G, analogs thereof and uses thereof | Jun 28, 2000 | Issued |
| 60/327556 | Pituitary adenylate cyclase activating peptide (Pacap) receptor 3(R3) agonists and their pharmacological methods of use | Jun 14, 2000 | Pending |
Array
(
[id] => 1262202
[patent_doc_number] => 06664373
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'TWIK-5 potassium channel polypeptides and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/561763
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 48161
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664373.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561763
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561763 | TWIK-5 potassium channel polypeptides and uses therefor | Apr 27, 2000 | Issued |
Array
(
[id] => 1453246
[patent_doc_number] => 06461836
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof'
[patent_app_type] => B1
[patent_app_number] => 09/545944
[patent_app_country] => US
[patent_app_date] => 2000-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13300
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461836.pdf
[firstpage_image] =>[orig_patent_app_number] => 09545944
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/545944 | Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof | Apr 9, 2000 | Issued |
Array
(
[id] => 1063291
[patent_doc_number] => 06849727
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-01
[patent_title] => 'DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/538036
[patent_app_country] => US
[patent_app_date] => 2000-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 39
[patent_no_of_words] => 45427
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849727.pdf
[firstpage_image] =>[orig_patent_app_number] => 09538036
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/538036 | DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof | Mar 28, 2000 | Issued |
Array
(
[id] => 1435803
[patent_doc_number] => 06355446
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'DocosahexAenoic acid as retinoid X-receptor ligand and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/534774
[patent_app_country] => US
[patent_app_date] => 2000-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 2948
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355446.pdf
[firstpage_image] =>[orig_patent_app_number] => 09534774
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/534774 | DocosahexAenoic acid as retinoid X-receptor ligand and uses thereof | Mar 23, 2000 | Issued |
| 09/523860 | Novel Compounds | Mar 12, 2000 | Abandoned |
Array
(
[id] => 1384290
[patent_doc_number] => 06548270
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'DNA encoding human acid-sensing ion channel BNaC4 (ASIC4)'
[patent_app_type] => B1
[patent_app_number] => 09/518959
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 23382
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548270.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518959
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518959 | DNA encoding human acid-sensing ion channel BNaC4 (ASIC4) | Mar 2, 2000 | Issued |
Array
(
[id] => 1123095
[patent_doc_number] => 06794161
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-21
[patent_title] => 'Potassium channels and genes encoding these potassium channels'
[patent_app_type] => B1
[patent_app_number] => 09/492361
[patent_app_country] => US
[patent_app_date] => 2000-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 13
[patent_no_of_words] => 18218
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794161.pdf
[firstpage_image] =>[orig_patent_app_number] => 09492361
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492361 | Potassium channels and genes encoding these potassium channels | Jan 26, 2000 | Issued |
Array
(
[id] => 1311673
[patent_doc_number] => 06610511
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Drosophila odorant receptors'
[patent_app_type] => B1
[patent_app_number] => 09/491577
[patent_app_country] => US
[patent_app_date] => 2000-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 31
[patent_no_of_words] => 95671
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610511.pdf
[firstpage_image] =>[orig_patent_app_number] => 09491577
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/491577 | Drosophila odorant receptors | Jan 24, 2000 | Issued |
| 09/490422 | Multipotent neural stem cells from peripheral tissues and uses therefor | Jan 23, 2000 | Abandoned |
| 09/488730 | METHOD OF PREDICTING THE GENETIC PREDISPOSITION TO OR STATUS AND PROGNOSIS OF BREAST CANCER IN A PATIENT | Jan 19, 2000 | Abandoned |